ASX - By Stock
|
SPL |
Re:
New COMPETITION for antiviral nasal sprays
|
|
24681357
|
32 |
8.7K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
32
|
8.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Slow death
|
|
24681357
|
39 |
9.7K |
3 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
39
|
9.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Slow death
|
|
24681357
|
39 |
9.7K |
1 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
39
|
9.7K
|
1
|
|
ASX - By Stock
|
SPL |
Slow death
|
|
24681357
|
39 |
9.7K |
3 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
39
|
9.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
24681357
|
44 |
10K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
44
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
24681357
|
22 |
4.9K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
4.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Fundamental Shafting
|
|
24681357
|
6 |
1.8K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
6
|
1.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
24681357
|
72 |
14K |
0 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
72
|
14K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
24681357
|
72 |
14K |
2 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
72
|
14K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
24681357
|
72 |
14K |
2 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
72
|
14K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
24681357
|
37 |
9.0K |
4 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
37
|
9.0K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
24681357
|
133 |
30K |
2 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
133
|
30K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
24681357
|
133 |
30K |
2 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
133
|
30K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
3603 days
|
|
24681357
|
5 |
1.4K |
1 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
5
|
1.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Another ADC Buyout - Just not SPL
|
|
24681357
|
23 |
6.0K |
2 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
23
|
6.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM Results
|
|
24681357
|
9 |
2.8K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
9
|
2.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma Presents at Bell Potter Conference
|
|
24681357
|
21 |
5.8K |
2 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
21
|
5.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
24681357
|
32 |
8.0K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
32
|
8.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Is SPL dying?
|
|
24681357
|
11 |
3.4K |
6 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
11
|
3.4K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
24681357
|
33 |
10K |
4 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
33
|
10K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
The past
|
|
24681357
|
20 |
6.1K |
1 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
20
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
24681357
|
25 |
6.6K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
25
|
6.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Clinical Trial Update
|
|
24681357
|
69 |
21K |
1 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
69
|
21K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma after 22 years
|
|
24681357
|
38 |
12K |
6 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
38
|
12K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
PATIENCE
|
|
24681357
|
54 |
17K |
1 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
54
|
17K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
24681357
|
77 |
20K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
77
|
20K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Dr Jeff Davies appointed as non-executive director
|
|
24681357
|
24 |
5.0K |
3 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
24
|
5.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Track Record
|
|
24681357
|
109 |
24K |
10 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
109
|
24K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
Complaint to the ASX regarding SPL
|
|
24681357
|
4 |
2.1K |
7 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
4
|
2.1K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE distribution and supply to Vietnam
|
|
24681357
|
124 |
31K |
7 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
124
|
31K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow and Activities Report
|
|
24681357
|
42 |
11K |
4 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
42
|
11K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE distribution and supply to Vietnam
|
|
24681357
|
124 |
31K |
2 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
124
|
31K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE distribution and supply to Vietnam
|
|
24681357
|
124 |
31K |
14 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
124
|
31K
|
14
|
|
ASX - By Stock
|
SPL |
Re:
Looking forward to a heap of positive announcements
|
|
24681357
|
47 |
9.0K |
7 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
47
|
9.0K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE distribution and supply to Vietnam
|
|
24681357
|
124 |
31K |
10 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
124
|
31K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chairman and CEO
|
|
24681357
|
26 |
5.7K |
5 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
26
|
5.7K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE ADMENTA agreement - supplementary information
|
|
24681357
|
93 |
22K |
1 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
93
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
There has been a whole lot of negativity on this forum lately and rightly so
|
|
24681357
|
27 |
5.6K |
9 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
27
|
5.6K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Why are you here
|
|
24681357
|
25 |
6.8K |
2 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
25
|
6.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Why are you here
|
|
24681357
|
25 |
6.8K |
2 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
25
|
6.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE ADMENTA agreement - supplementary information
|
|
24681357
|
93 |
22K |
1 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
93
|
22K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Why are you here
|
|
24681357
|
25 |
6.8K |
7 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
25
|
6.8K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Anti Mgt Rethoic
|
|
24681357
|
20 |
6.1K |
9 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
20
|
6.1K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Provisional approval from TGA
|
|
24681357
|
13 |
4.3K |
9 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
13
|
4.3K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Has Starpharma applied to the TGA?
|
|
24681357
|
147 |
39K |
8 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
147
|
39K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Potential breach of Listing Rules
|
|
24681357
|
31 |
9.6K |
5 |
24/07/21 |
24/07/21 |
ASX - By Stock
|
31
|
9.6K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Potential breach of Listing Rules
|
|
24681357
|
31 |
9.6K |
2 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
31
|
9.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Potential breach of Listing Rules
|
|
24681357
|
31 |
9.6K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
31
|
9.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Too much negativity
|
|
24681357
|
98 |
22K |
2 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
98
|
22K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Too much negativity
|
|
24681357
|
98 |
22K |
1 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
98
|
22K
|
1
|
|